Papers/PMID:27683225
Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis.
Endocrine2017The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
selenium atom — no detected effect on health-related quality of life
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“Compared to control groups, there were no significant changes in any of the eight SF-36 domains following 6 months of selenium supplementation in two trials enrolling LT4-untreated individuals (data not shown).”
Quoted verbatim from Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis.. - Study
- meta-analysis
- Duration
- 6 months
- Population
- Adults with chronic autoimmune thyroiditis not treated with levothyroxine; two trials, 6 months of selenium supplementation
Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis.2017PMID:27683225Permalink